![Dysport: instructions for using the medicine, structure, Contraindications - Instructions for use, Description medicines. D - Medicine and health Dysport: instructions for using the medicine, structure, Contraindications - Instructions for use, Description medicines. D - Medicine and health](https://omedicine.info/wp-content/uploads/2010/10/dysport.jpg)
Dysport: instructions for using the medicine, structure, Contraindications - Instructions for use, Description medicines. D - Medicine and health
![Dysport 500 Iu Ipsen Injection General Medicines at Best Price in Istanbul | Yeniemre Dis Ticaret Ve Saglik Urunleri Ltd Sti Dysport 500 Iu Ipsen Injection General Medicines at Best Price in Istanbul | Yeniemre Dis Ticaret Ve Saglik Urunleri Ltd Sti](https://tiimg.tistatic.com/fp/1/006/472/dysport-500-iu-ipsen-injection-444.jpg)
Dysport 500 Iu Ipsen Injection General Medicines at Best Price in Istanbul | Yeniemre Dis Ticaret Ve Saglik Urunleri Ltd Sti
![Ipsen Biopharmaceuticals, Inc. announces FDA approval of Dysport® (abobotulinumtoxinA) for the treatment of lower limb spasticity in pediatric patients aged two and older Ipsen Biopharmaceuticals, Inc. announces FDA approval of Dysport® (abobotulinumtoxinA) for the treatment of lower limb spasticity in pediatric patients aged two and older](https://www.multivu.com/players/English/7876651-ipsen-biopharma-fda-approval-dysport/image/product-shot-4-512X288.jpg)
Ipsen Biopharmaceuticals, Inc. announces FDA approval of Dysport® (abobotulinumtoxinA) for the treatment of lower limb spasticity in pediatric patients aged two and older
![Ipsen Announces Updated Indication for Dysport® (abobotulinumtoxinA) for the Treatment of Spasticity in Children | Business Wire Ipsen Announces Updated Indication for Dysport® (abobotulinumtoxinA) for the Treatment of Spasticity in Children | Business Wire](https://mms.businesswire.com/media/20200709005981/en/746266/23/1280px-Ipsen_logo.svg.jpg)
Ipsen Announces Updated Indication for Dysport® (abobotulinumtoxinA) for the Treatment of Spasticity in Children | Business Wire
![Ipsen Announces Updated Indication for Dysport® (abobotulinumtoxinA) for the Treatment of Spasticity in Children | Business Wire Ipsen Announces Updated Indication for Dysport® (abobotulinumtoxinA) for the Treatment of Spasticity in Children | Business Wire](https://mms.businesswire.com/media/20200709005981/en/746266/22/1280px-Ipsen_logo.svg.jpg)